INFLIXIMAB
infliximab 100 mg injection, 1 vial
INFLIXIMAB (4284L)
4284L
Manner of administration:Injection
Restriction
Indication: Rheumatoid arthritis
Treatment phase: Initial treatment
Restriction
Indication: Rheumatoid arthritis
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 2 | DPMQ: - | Max safety net: - | General Patient Charge: - |
| Available brands | |||||
| Remicade | DPMQ: $215.63 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||